Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cibenzoline is an antiarrhythmic agent that inhibits the KATP channel by directly affecting the pore-forming Kir6.2 subunit rather than the SUR1 subunit. Cibenzoline shows little anticholinergic activity. Cibenzoline markedly reduces LVPG which has a close relationship with myocardial contractility decreasing. Cibenzoline has the potential for hypertrophic obstructive cardiomyopathy research[1][2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,370 | 6-8 weeks | |
50 mg | $1,780 | 6-8 weeks | |
100 mg | $2,670 | 6-8 weeks |
Description | Cibenzoline is an antiarrhythmic agent that inhibits the KATP channel by directly affecting the pore-forming Kir6.2 subunit rather than the SUR1 subunit. Cibenzoline shows little anticholinergic activity. Cibenzoline markedly reduces LVPG which has a close relationship with myocardial contractility decreasing. Cibenzoline has the potential for hypertrophic obstructive cardiomyopathy research[1][2]. |
Molecular Weight | 262.35 |
Formula | C18H18N2 |
Cas No. | 53267-01-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.